EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic Potential of Ginger Rhizomes ( Zingiber officinale ) on Leukemia

Abdolhossein Hajizadeh, Parmida Nafei, Kimiya Seraj iD, Faranak Zargari, Nassim Rastgar, Farshad Zare, Obid Khamidov, Ghadeer Mohammed Ali Basha, Mustafa Sattar, Mehdi Amirhooshangi, Nima Ghavamikia, Payam Ali-Khiavi iD

Biotechnology and Applied Biochemistry · 2026-08 · 73 (4) · 2102-2113

DOI: 10.1002/bab.70130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 29.01.2026. Verfasst von Abdolhossein Hajizadeh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Zingiber officinale, Leukemia, Rhizome, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukemia continues to provide a significant therapeutic challenge due to relapse, medication resistance, and treatment‐associated toxicity, which frequently hinder sustained disease management. Rhizomes of ginger ( Zingiber officinale ) possess bioactive phenolics, notably 6‐gingerol and 6‐shogaol derivatives, which have demonstrated antileukemia efficacy in preclinical models. This study rigorously assesses the evidence regarding ginger‐derived preparations and isolated compounds in both acute and chronic leukemia models, focusing on recurring mechanisms and translational viability. In leukemia cell line investigations and sparse resistant‐model data, ginger‐related interventions are consistently linked to diminished viability and the induction of mitochondrial apoptosis, typically indicated by alterations in Bax/Bcl‐2 ratios, PARP breakage, and caspase‐related measurements. Numerous studies indicate redox modulation, often characterized by elevated intracellular reactive oxygen species in leukemic cells, coupled with diminished pro‐survival signaling, such as PI3K/Akt, as indicated by decreased pAkt and survivin levels. The suggested immunomodulatory and anti‐inflammatory effects, encompassing alterations in NK‐cell activity and cytokines like TNF‐α and IL‐6, are inadequately substantiated within leukemia‐specific immunological contexts. Interpretation is limited by the variability in extract composition and chemical characterisation, inconsistent dose and exposure circumstances, dependence on endpoint markers without causative manipulation, and a lack of leukemia‐specific clinical data. Ginger‐derived compounds exhibit multi‐target biological activity that necessitates further exploration through standardized and chemically defined preparations, pharmacokinetic and pharmacodynamic characterization, clinically relevant exposure benchmarks, and meticulously designed leukemia‐focused translational and early‐phase clinical studies to elucidate safety, efficacy, and compatibility with current therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zingiber officinaleLeukemiaRhizomeAntineoplastic Agents, PhytogenicHumansAnimalsApoptosisCatechols

Stichwörter der Autor:innen

cancerginger rhizomesleukemiamolecular mechanisms

Substanzen

Antineoplastic Agents, PhytogenicCatechols

Autor:innen und Institutionen

  • Shiraz University of Medical Sciences, Shiraz, Iran.
  • Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Faculty of Pharmacy, Hamedan University of Medical Science, Hamedan, Iran.
  • Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, West Azerbaijan, Iran.
  • Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Kimiya Seraj, Payam Ali-Khiavi

Zitieren

APA

Hajizadeh, A., Nafei, P., Seraj, K., Zargari, F., Rastgar, N., Zare, F., Khamidov, O., Basha, G. M. A., Sattar, M., Amirhooshangi, M., Ghavamikia, N., & Ali-Khiavi, P. (2026). Therapeutic Potential of Ginger Rhizomes ( Zingiber officinale ) on Leukemia. Biotechnology and Applied Biochemistry, 73(4), 2102-2113. https://doi.org/10.1002/bab.70130

Vancouver

Hajizadeh A, Nafei P, Seraj K, Zargari F, Rastgar N, Zare F, et al. Therapeutic Potential of Ginger Rhizomes ( Zingiber officinale ) on Leukemia. Biotechnology and Applied Biochemistry. 2026;73(4):2102-2113. doi:10.1002/bab.70130

BibTeX
@article{Hajizadeh2026,
  author = {Hajizadeh, Abdolhossein and Nafei, Parmida and Seraj, Kimiya and Zargari, Faranak and Rastgar, Nassim and Zare, Farshad and Khamidov, Obid and Basha, Ghadeer Mohammed Ali and Sattar, Mustafa and Amirhooshangi, Mehdi and Ghavamikia, Nima and Ali-Khiavi, Payam},
  title = {Therapeutic Potential of Ginger Rhizomes ( Zingiber officinale ) on Leukemia},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2026},
  volume = {73},
  number = {4},
  pages = {2102--2113},
  doi = {10.1002/bab.70130}
}
Kostenlos starten →